Variant report
Variant | esv3386750 |
---|---|
Chromosome Location | chr20:11125875-11126447 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558675608 | chr20:11125887-11125888 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs112134738 | chr20:11125925-11125926 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73255581 | chr20:11125934-11125935 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs541089912 | chr20:11125951-11125952 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs138977546 | chr20:11125956-11125957 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561717452 | chr20:11125980-11125981 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530080422 | chr20:11126036-11126037 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs116797126 | chr20:11126053-11126054 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12481309 | chr20:11126060-11126061 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs559993986 | chr20:11126155-11126156 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376607710 | chr20:11126182-11126183 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531452279 | chr20:11126183-11126184 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs76153089 | chr20:11126229-11126230 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs79504062 | chr20:11126231-11126232 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187060307 | chr20:11126258-11126259 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571424395 | chr20:11126261-11126262 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs527399129 | chr20:11126308-11126309 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547487906 | chr20:11126369-11126370 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564394903 | chr20:11126382-11126383 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs149427605 | chr20:11126383-11126384 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs374911972 | chr20:11126384-11126385 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs73606428 | chr20:11126409-11126410 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs374863427 | chr20:11126428-11126429 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16397240 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Glaucoma | 21310917 | CNVD |
Alagille syndrome | 22470819 | CNVD |
Lung cancer | 16773561 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21804112 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 20409316 | CNVD |
Cancer | 20164919 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:11125200-11126800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr20:11125400-11126200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
3 | chr20:11125400-11126200 | Enhancers | NHDF-Ad | bronchial |
4 | chr20:11125400-11126800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr20:11125400-11134200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr20:11125600-11126200 | Weak transcription | Fetal Muscle Leg | muscle |
7 | chr20:11125600-11126600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr20:11126200-11126400 | Enhancers | Fetal Muscle Leg | muscle |